Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
, 64 (1), 17-21

Pharmacokinetics of Benzylpenicillin (Penicillin G) During Prolonged Intermittent Renal Replacement Therapy

Affiliations
Case Reports

Pharmacokinetics of Benzylpenicillin (Penicillin G) During Prolonged Intermittent Renal Replacement Therapy

Vesa Cheng et al. Chemotherapy.

Abstract

Prolonged intermittent renal replacement therapy (PIRRT) is an increasingly adopted method of renal replacement in critically ill patients. Like continuous renal replacement therapy, PIRRT can alter the pharmacokinetics (PK) of many drugs. In this setting, dosing data for antibiotics like benzylpenicillin are lacking. In order to enable clinicians to prescribe benzylpenicillin safely and effectively, knowledge of the effects of PIRRT on the plasma PK of benzylpenicillin is required. Herein, we describe the PK of benzylpenicillin in 2 critically ill patients on PIRRT for the treatment of penicillin-susceptible Staphylococcus aureus bacteremia complicated by infective endocarditis. Blood samples were taken for each patient taken over dosing periods during PIRRT and off PIRRT. Two-compartment PK models described significant differences in the mean clearance of benzylpenicillin with and without PIRRT (6.61 vs. 3.04 L/h respectively). We would suggest a benzylpenicillin dose of 1,800 mg (3 million units) every 6-h during PIRRT therapy as sufficient to attain PK/pharmacodynamic target.

Keywords: Antibiotics; Dosing; Extended daily dialysis; Penicillin G; Renal replacement therapy; Sustained low efficiency dialysis.

Similar articles

See all similar articles

Publication types

MeSH terms

Feedback